Pathway
|
Prolactin Production
|
|
Nociception Expression Targets Signaling
|
|
NTSR1 Expression Targets
|
|
DRD2 Expression Targets
|
|
DRD2 -> TRPC1 Transcription
|
|
NTRK1/2/3 -> Acetylcholine Production
|
|
Endothelial Cell Dysfunction in Arterial Hypertension
|
|
Smooth Muscle Cell Dysfunction in Pulmonary Hypertension
|
|
IL22 Induces Keratinocyte Proliferation in Psoriasis
|
|
Insulin Resistance in Hepatocytes
|
|
Prolactinoma Overiew
|
|
Hodgkin Lymphoma
|
|
Hepatocellular Carcinoma
|
|
Growth Factor Signaling in Hepatocellular Carcinoma
|
|
Pancreatic Ductal Carcinoma
|
|
IL6 Promotes Inflammation in Muscular Dystrophies
|
|
Medulloblastoma
|
|
Growth Factor Signaling in Neuroblastoma
|
|
Neuroblastoma
|
|
Endometrial Cancer
|
|
Endometrioid Endometrial Cancer
|
|
Clear Cell Ovarian Carcinoma
|
|
High-Grade Serous Ovarian Carcinoma
|
|
Ovarian Cancer
|
|
EGF/cyclinD1 Signaling in Acquired Middle Ear Cholesteatoma
|
|
Subepithelial Fibroblasts in Middle Ear Cholesteatoma
|
|
Cholesteatoma
|
|
HPV E5 Regulates EDNRA and EGFR Signaling Pathway in Keratinocytes
|
|
Steroids Induced Cataract
|
|
Neurotrophic Factor Deprivation in Retinal Ganglion Cell Death
|
|
Cytokines Trigger Otitis Media
|
|
AREG -> NFATC Expression Target
|
|
AREG -> CREB/CREBBP Expression Targets
|
|
AREG -> NCOR2 Expression Targets
|
|
AREG -> HIF1A Expression Targets
|
|
AREG -> AP-1 Expression Targets
|
|
AREG -> FOXO3A Expression Target
|
|
Dopamine/Gi Expression Targets
|
|
BTC -> NFATC Expression Targets
|
|
BTC -> AP-1/ATF/CREB Expression Targets
|
|
Tamoxifen Induced Endometrial Cancer
|
|
EGF -> HIF1A Expression Targets
|
|
EGF -> AP-1/ATF Expression Targets
|
|
EGF -> CREB/CREBBP/ELK/SRF/MYC Expression Targets
|
|
EGF -> MEF/MYOD/NFATC Expression Targets
|
|
EGF -> FOXO3A Expression Targets
|
|
EGF -> TP53 Expression Targets
|
|
EGF -> NCOR2 Expression Target
|
|
EGFR -> NCOR2 Signaling
|
|
EGFR/ERBB3 -> MEF/MYOD/NFATC/MYOG Signaling
|
|
EGFR/ERBB2 -> TP53 Signaling
|
|
EGFR/ERBB2 -> HIF1A Signaling
|
|
EGFR -> AP-1/ATF2 Signaling
|
|
EGFR -> AP-1/CREB/ELK/SRF/MYC Signaling
|
|
EREG -> CREB Expression Target
|
|
EREG -> FOXO3A Expression Target
|
|
EREG -> HIF1A Expression Target
|
|
EREG -> AP-1/ATF Expression Targets
|
|
F2 -> AP-1/CREB/ELK/SRF/SP1 Expression Targets
|
|
F2 -> STAT1/NF-kB Expression Targets
|
|
PLG -> AP-1/CREB/ELK/SRF/SP1 Expression Targets
|
|
PLG -> STAT1/NF-kB Expression Targets
|
|
HBEGF -> FOXO3A Expression Target
|
|
HBEGF -> AP-1/ATF Expression Targets
|
|
HBEGF -> TP53 Expression Targets
|
|
HBEGF -> HIF1A Expression Targets
|
|
HBEGF -> MEF/MYOD Expression Target
|
|
HBEGF -> CREB/MYC Expression Targets
|
|
Receptors and Adaptor Proteins Activated in Cancer
|
|
Proteins with Altered Expression in Cancer-Associated Sustaining of Proliferative Signaling
|
|
Genes with Mutations in Cancer-Associated Sustaining of Proliferative Signaling
|
|
VEGF Independent Angiogenesis in Cancer
|
|
Hyaluronic Acid, CD44 and HMMR in Cancer Cell Invasion and Survival
|
|
LPA Expression Targets
|
|
NRG1 -> MEF/MYOD Expression Targets
|
|
NRG1 -> CREB/CREBBP/ELK/SRF/MYC Expression Targets
|
|
NRG1 -> FOXO3A Expression Targets
|
|
NRG1 -> TP53 Expression Target
|
|
NRG1 -> AP-1/ATF Expression Targets
|
|
NRG1 -> HIF1A Expression Target
|
|
NGF -> SMAD3/NF-kB Expression Targets
|
|
NGF -> AP-1/TP53/MYC Expression Targets
|
|
NGF -> FOXO/MYCN/ELK-SRF Expression Targets
|
|
NGF -> CREB/CEBPB/MEF2A Expression Targets
|
|
AVP/Gs -> CREB/ELK/SRF/AP-1/EGR Expression Targets
|
|
NTS Expression Targets
|
|
AVP/Gs -> MEF/MYOD/NFATC/MYOG Expression Targets
|
|
AVP/Gq -> MEF/MYOD/NFATC/MYOG Expression Targets
|
|
AVP/Gq -> CREB/ELK/SRF/AP-1/EGR Expression Targets
|
|
NTRK -> FOXO/MYCN Signaling
|
|
NTRK -> AP-1/CREB/ELK/SRF/MYC/SMAD3/TP53 Signaling
|
|
FOXO1 Signaling
|
|
PI3K/RAC1 Signaling
|
|
ERK5/MAPK7 Signaling
|
|
ERK/MAPK Canonical Signaling
|
|
TGFA -> FOXO3A Expression Targets
|
|
TGFA -> TP53 Expression Targets
|
|
TGFA -> HIF1A Expression Targets
|
|
TGFA -> MEF/MYOD/NFATC Expression Targets
|
|
TGFA/AP-1/ATF Expression Targets
|
|
TGFA -> CREB/CREBBP/ELK-SRF/MYC Expression Targets
|
|
2_Interleukin-17 and interleukin-22 signaling in psoriasis
|
|
3_Mesangial cell dysfunction in glomerulonephritis
|
|
3_Role of neurotrophic factor deprivation in retinal ganglion cell death
|
|
4_2_Airway smooth muscle cells proliferation and airway tissue remodeling
|
|
Interleukin-17 and interleukin-22 signaling in psoriasis
|